Immunitybioincis A Clinical Stage Biotechnology Company Based In Culver Citycaliforniafounded By Drpatrick Soon Shiongthe Company Focuses On Developing Innovative Therapies And Vaccines That Enhance The Immune System To Combat Cancer And Infectious Diseasesas A Subsidiary Of Nantworks Llcimmunitybio Manages Various Stages Of Its Product Development And Manufacturing Processes The Company Is Actively Engaged In Several Key Research Areasincluding Cancer Immunotherapies For Multiple Myeloma And Solid Tumorsas Well As Covid 19 Vaccine Developmentits Clinical Pipeline Features Products Like Anktivawhich Is In Phase 3 For Bladder Cancerand Other Therapies Targeting Lymphopenia And Pancreatic Cancerimmunitybio Also Collaborates With Other Biotech Firmsexemplified By Its Agreement With Beigeneltdfor A Phase 3 Trial In Non Small Cell Lung Cancerwith A Dedicated Team Of Approximately 680 Employeesimmunitybio Is Committed To Advancing Next Generation Treatments Tailored To Individual Patient Needs
